| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Jun'18 | |
|---|---|---|---|---|---|---|
Assets | ||||||
Cash and due from banks | ||||||
22 | 24 | 41 | 48 | 38 | 23 | |
Federal funds sold | ||||||
4 | 0 | 4 | 2 | 4 | 8 | |
Interest-earning deposits with banks | ||||||
163 | 89 | 142 | 179 | 114 | 88 | |
Cash and cash equivalents | ||||||
190 | 114 | 188 | 230 | 156 | 120 | |
Securities available for sale | ||||||
73 | - | - | 91 | - | - | |
Securities available for sale, at fair value | ||||||
- | 87 | 91 | - | - | - | |
Securities available for sale, at fair value | ||||||
- | - | - | - | 94 | 88 | |
Securities held to maturity (fair value of $4,182 at March 31, 2020; and $3,887 at June 30, 2019) | ||||||
4 | 4 | 3 | 3 | 4 | 5 | |
Equity securities | ||||||
2 | 3 | 3 | 3 | - | - | |
Federal Home Loan Bank of New York stock | ||||||
1 | 1 | 0 | 0 | 0 | 0 | |
Net loans receivable | ||||||
1,101 | 1,079 | 1,054 | 1,053 | 1,040 | 985 | |
Accrued interest receivable | ||||||
4 | 4 | 4 | 4 | 4 | 3 | |
Premises and equipment, net | ||||||
41 | 41 | 41 | 41 | 41 | 42 | |
Bank-owned life insurance | ||||||
17 | 17 | 17 | 17 | 17 | 17 | |
Goodwill | ||||||
7 | 7 | 7 | 7 | 7 | 7 | |
Other intangible assets, net | ||||||
2 | 2 | 2 | 2 | 2 | 2 | |
Other assets | ||||||
52 | 27 | 34 | 22 | 15 | 9 | |
Total assets | ||||||
1,499 | 1,391 | 1,449 | 1,479 | 1,385 | 1,284 | |
Liabilities and Shareholders' Equity | ||||||
Liabilities: | ||||||
Deposits: | ||||||
Non-interest bearing deposits | ||||||
369 | 351 | 410 | 357 | 380 | 345 | |
Interest bearing deposits | ||||||
868 | 788 | 804 | 973 | 863 | 805 | |
Total deposits | ||||||
1,237 | 1,139 | 1,214 | 1,331 | 1,243 | 1,150 | |
Mortgagors’ escrow deposits | ||||||
3 | 5 | 2 | 6 | 3 | 5 | |
Borrowings from Federal Home Loan Bank of New York | ||||||
20 | 10 | - | - | - | - | |
Other liabilities | ||||||
9 | 8 | 8 | 7 | 6 | 10 | |
Total liabilities | ||||||
1,271 | 1,163 | 1,226 | 1,345 | 1,253 | 1,166 | |
Shareholders' Equity | ||||||
Common stock ($0.01 par value, 75,000,000 shares authorized, 25,977,679 shares issued and outstanding as of March 31, 2020) | ||||||
0 | 0 | 0 | - | - | - | |
Additional paid in capital | ||||||
114 | 114 | 114 | - | - | - | |
Surplus | ||||||
- | - | - | - | 10 | 10 | |
Retained earnings | ||||||
138 | 138 | 134 | 146 | 130 | 116 | |
Unallocated common stock of Employee Stock Ownership Plan ("ESOP") | ||||||
12 | 12 | 13 | - | - | - | |
Accumulated other comprehensive loss | ||||||
-11 | -11 | -11 | -11 | -9 | -8 | |
Total shareholders' equity | ||||||
228 | 227 | 223 | 134 | 131 | 118 | |
Total liabilities and shareholders' equity | ||||||
1,499 | 1,391 | 1,449 | 1,479 | 1,385 | 1,284 | |